Winslow Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,330
| Closed | -$206K | – | 81 |
|
|
2026
Q1 | $206K | Buy |
+7,330
| New | +$195K | 0.04% | 77 |
|
|
2025
Q1 | – | Sell |
-7,981
| Closed | -$212K | – | 77 |
|
|
2024
Q4 | $212K | Sell |
7,981
-216
| -3% | -$5.86K | 0.04% | 74 |
|
|
2024
Q3 | $237K | Sell |
8,197
-981
| -11% | -$28.6K | 0.04% | 71 |
|
|
2024
Q2 | $257K | Sell |
9,178
-1,407
| -13% | -$38.7K | 0.05% | 67 |
|
|
2024
Q1 | $294K | Sell |
10,585
-500
| -5% | -$13.9K | 0.06% | 66 |
|
|
2023
Q4 | $319K | Sell |
11,085
-1,820
| -14% | -$55K | 0.06% | 65 |
|
|
2023
Q3 | $428K | Sell |
12,905
-30
| -0.2% | -$1.06K | 0.1% | 57 |
|
|
2023
Q2 | $474K | Hold |
12,935
| – | – | 0.1% | 56 |
|
|
2023
Q1 | $528K | Sell |
12,935
-83
| -0.6% | -$3.58K | 0.12% | 55 |
|
|
2022
Q4 | $667K | Sell |
13,018
-1,103
| -8% | -$52.9K | 0.16% | 55 |
|
|
2022
Q3 | $618K | Sell |
14,121
-1
| -0% | -$49 | 0.16% | 56 |
|
|
2022
Q2 | $740K | Buy |
14,122
+250
| +2% | +$12.7K | 0.18% | 53 |
|
|
2022
Q1 | $718K | Sell |
13,872
-250
| -2% | -$13K | 0.14% | 60 |
|
|
2021
Q4 | $834K | Hold |
14,122
| – | – | 0.15% | 59 |
|
|
2021
Q3 | $607K | Hold |
14,122
| – | – | 0.12% | 63 |
|
|
2021
Q2 | $553K | Hold |
14,122
| – | – | 0.1% | 64 |
|
|
2021
Q1 | $512K | Hold |
14,122
| – | – | 0.1% | 61 |
|
|
2020
Q4 | $520K | Sell |
14,122
-763
| -5% | -$28K | 0.11% | 62 |
|
|
2020
Q3 | $518K | Buy |
14,885
+21
| +0.1% | +$736 | 0.13% | 60 |
|
|
2020
Q2 | $461K | Hold |
14,864
| – | – | 0.12% | 59 |
|
|
2020
Q1 | $460K | Hold |
14,864
| – | – | 0.15% | 60 |
|
|
2019
Q4 | $553K | Hold |
14,864
| – | – | 0.13% | 66 |
|
|
2019
Q3 | $507K | Hold |
14,864
| – | – | 0.13% | 66 |
|
|
2019
Q2 | $611K | Hold |
14,864
| – | – | 0.14% | 66 |
|
|
2019
Q1 | $599K | Hold |
14,864
| – | – | 0.13% | 65 |
|
|
2018
Q4 | $616K | Buy |
14,864
+2,361
| +19% | +$98K | 0.14% | 68 |
|
|
2018
Q3 | $523K | Sell |
12,503
-7,640
| -38% | -$294K | 0.1% | 71 |
|
|
2018
Q2 | $693K | Hold |
20,143
| – | – | 0.13% | 67 |
|
|
2018
Q1 | $678K | Hold |
20,143
| – | – | 0.13% | 66 |
|
|
2017
Q4 | $692K | Hold |
20,143
| – | – | 0.13% | 66 |
|
|
2017
Q3 | $682K | Hold |
20,143
| – | – | 0.13% | 67 |
|
|
2017
Q2 | $642K | Sell |
20,143
-1,344
| -6% | -$42.4K | 0.13% | 66 |
|
|
2017
Q1 | $697K | Sell |
21,487
-29
| -0.1% | -$914 | 0.14% | 66 |
|
|
2016
Q4 | $663K | Hold |
21,516
| – | – | 0.14% | 67 |
|
|
2016
Q3 | $691K | Hold |
21,516
| – | – | 0.15% | 67 |
|
|
2016
Q2 | $719K | Sell |
21,516
-157
| -0.7% | -$5.01K | 0.16% | 67 |
|
|
2016
Q1 | $609K | Sell |
21,673
-106
| -0.5% | -$3.03K | 0.14% | 66 |
|
|
2015
Q4 | $667K | Sell |
21,779
-1,001
| -4% | -$31.5K | 0.13% | 67 |
|
|
2015
Q3 | $679K | Sell |
22,780
-264
| -1% | -$8.46K | 0.13% | 66 |
|
|
2015
Q2 | $733K | Hold |
23,044
| – | – | 0.13% | 66 |
|
|
2015
Q1 | $761K | Hold |
23,044
| – | – | 0.13% | 64 |
|
|
2014
Q4 | $681K | Hold |
23,044
| – | – | 0.11% | 67 |
|
|
2014
Q3 | $646K | Buy |
23,044
+37
| +0.2% | +$1.04K | 0.11% | 65 |
|
|
2014
Q2 | $648K | Hold |
23,007
| – | – | 0.11% | 65 |
|
|
2014
Q1 | $701K | Buy |
23,007
+232
| +1% | +$6.92K | 0.12% | 63 |
|
|
2013
Q4 | $662K | Hold |
22,775
| – | – | 0.12% | 61 |
|
|
2013
Q3 | $621K | Hold |
22,775
| – | – | 0.12% | 62 |
|
|
2013
Q2 | $605K | Buy |
+22,775
| New | +$629K | 0.12% | 61 |
|
Other funds holding PFE
Winslow Asset Management's PFE Position: Q2 2026 in Review
Winslow Asset Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,330 shares — an estimated $206K sold.
Winslow Asset Management first reported a position in PFE in Q2 2013 and held it in 48 quarters. The position peaked at $834K in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Winslow Asset Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Winslow Asset Management sold 7,330 Pfizer shares in Q2 2026, an estimated $206K.
- Winslow Asset Management first reported a position in Pfizer in Q2 2013 and held it in 48 quarters.
- Winslow Asset Management's Pfizer position peaked at $834K in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Winslow Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.